Search results

620 results

Sorted by Relevance . Sort by Date

  1. Inducing labour (update)

    In development [GID-NG10082] Expected publication date: 14 October 2021

  2. Acne Vulgaris: Management

    In development [GID-NG10109] Expected publication date: 09 June 2021

  3. Caesarean section (update)

    In development [GID-NG10081] Expected publication date: 31 March 2021

  4. Postnatal care

    In development [GID-NG10070] Expected publication date: 07 April 2021

  5. Diabetes update

    In development [GID-NG10152] Expected publication date: TBC

  6. Pernicious anaemia

    In development [GID-NG10176] Expected publication date: 23 March 2023

  7. Shared decision making

    In development [GID-NG10120] Expected publication date: 17 June 2021

  8. Antenatal care

    In development [GID-NG10096] Expected publication date: 11 August 2021

  9. Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast (DG37)

    Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. The tests are

  10. Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I (DG32)

    Evidence-based recommendations on 2 adjunctive colposcopy technologies (the DYSIS colposcope with DYSISmap and the ZedScan I) for assessing suspected cervical

  11. Biomarker tests to help diagnose preterm labour in women with intact membranes (DG33)

    Evidence-based recommendations on biomarker tests to help diagnose preterm labour in women with intact membranes. The tests are Actim Partus, PartoSure and the

  12. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34)

    Evidence-based recommendations on tumour profiling tests to guide adjuvant chemotherapy decisions for people with early breast cancer. The tests are EndoPredict

  13. SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver (DG5)

    Evidence-based recommendations on SonoVue (sulphur hexafluoride microbubbles) for contrast-enhanced ultrasound imaging of the liver

  14. SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection (DG7)

    Evidence-based recommendations on SeHCAT (tauroselcholic [75selenium] acid) for diagnosing bile acid malabsorption in people with IBS-D or Crohn’s disease

  15. Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis (DG29)

    Evidence-based recommendations on multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis